SRT Sartorius AG

Regulatory News:

For the sake of formality, Sartorius (FWB:SRT) as majority shareholder of Sartorius Stedim Biotech would like to remind that the period for calculation of the share price guarantee are the 30 trading days preceding July 27, 2009, i.e. from June 15 until July 24, 2009. In the following, the main characteristics of these guarantee rights will again be explained. All of the explanations given below are completely congruent with the statements made in the various press releases in the past, the 2007 and 2008 Annual Reports of Sartorius and the First-quarter Report of 2009 of Sartorius and, therefore, do not represent any new information. Furthermore, Sartorius has already accounted for these share price guarantees to the full extent in its 2008 annual financial statements and in its first-quarter statements of 2009.

Background

In fiscal 2007, the leading international laboratory and process equipment provider Sartorius AG acquired a majority stake and controlling interest in Stedim S.A., which since then has been officially named Sartorius Stedim Biotech S.A. This transaction was accompanied by a mandatory offer to the shareholders of Sartorius Stedim Biotech, which entailed granting a separate non-transferable share price guarantee to those shareholders who chose to remain invested.

Information on the characteristics of the guarantee rights are included in the offer prospectus published by Sartorius in the context of its simplified tender offer on Sartorius Stedim Biotech in July 2007, which has been available since then on the Sartorius website (www.sartorius.com) and on the AMF website (www.amf-france.org).

The main characteristics of the guarantee rights are set forth below.

Beneficiaries of the guarantee rights

Guarantee rights were granted by Sartorius to the following persons:

• Persons who held Sartorius Stedim Biotech shares on the offer closing date, i.e. July 26, 20071, one guarantee right being allocated for each Sartorius Stedim Biotech share held July 26, 2007 after the closing of the market; and
• Persons who held Sartorius Stedim Biotech stock options on the offer closing date, i.e. July 26, 2007, and who have exercised their options between the offer closing date and July 24, 2009, one guarantee right being allocated for each Sartorius Stedim Biotech share issued upon exercise of the options.

It is specified that the persons who have acquired Sartorius Stedim Biotech shares after July 26, 2007 do not benefit from guarantee rights in respect of the shares so acquired.

Non-transferability of the guarantee rights and separation from the shares

The guarantee rights are non-transferable, except in case of inheritance or universal transfer of assets.

They are also separated (�detached�) from the Sartorius Stedim Biotech shares in relation to which they were allocated; hence, in the event the beneficiaries of the guarantee rights sell the shares in respect of which the guarantee rights were allocated, the guarantee rights will remain registered in such beneficiaries� account.

Rights attached to the guarantee rights

• Each guarantee right gives right to the payment of a certain cash amount at the end of a 2-year period following the closing of Sartorius� offer, such period expiring on July 27, 2009 (the �Maturity Date�).
• Such amount is equal to the difference between the amount of 47.50 euros and the average closing price of the Sartorius Stedim Biotech share, weighted by trading volume, calculated over the 30 trading days preceding the Maturity Date (i.e. from June, 15, to July, 24, 2009), called �Reference Trading Price�.
• Such amount is capped at 20 euros per guarantee right.

Implementation of the guarantee rights

Within three days of the Maturity Date, i.e. on July 30, 2009 at the latest, Sartorius will publish a financial notice indicating the amount of the Reference Trading Price as well as the amount of the difference between 47.50 euros and the Reference Trading Price, corresponding to the amount due in respect of each guarantee right.

Euronext will also publish a notice indicating the amount and the modalities of the payment due in respect of the guarantee rights.

Payment will be made on Sartorius� behalf by BNP Paribas Securities Services, as paying agent, to the intermediaries with whom guarantee rights are registered. Such intermediaries will then credit the amount due to each beneficiaries of guarantee rights.

A Profile of Sartorius

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of biotechnology and mechatronics. In 2008, the technology group earned sales revenue of 611.6 million euros. Founded in 1870, the Goettingen-based company currently employs approximately 4,600 persons. The major areas of activity in its biotechnology segment focus on filtration, fluid management, fermentation, purification and laboratory applications. In the mechatronics segment, the company primarily manufactures equipment and systems featuring weighing, measurement and automation technology for laboratory and industrial applications. Key Sartorius customers are from the pharmaceutical, chemical and food and beverage industries and from numerous research and educational institutes of the public sector. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

This press release is for information purposes only. It shall not constitute an offer to purchase nor an invitation to make an offer to sell Sartorius Stedim Biotech shares.

____________________________________________________________________________

1 As an exception, as regards the Sartorius Stedim Biotech shares for which a transfer order was placed within the 3 days preceding the closing of the offer, the guarantee rights were allocated to the transferee of such shares, even though the shares were not yet registered in the transferee�s name on the date of allocation of the guarantee rights.

Sartorius (TG:SRT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Sartorius (TG:SRT)
Historical Stock Chart
From Nov 2023 to Nov 2024